Literature DB >> 29898878

Blood group ABO gene-encoded A transferase catalyzes the biosynthesis of FORS1 antigen of FORS system upon Met69Thr/Ser substitution.

Emili Cid1, Miyako Yamamoto1, Fumiichiro Yamamoto1,2.   

Abstract

Blood group A/B glycosyltransferases (AT/BTs) and Forssman glycolipid synthase (FS) are encoded by the evolutionarily related ABO (A/B alleles) and GBGT1 genes, respectively. AT/BT and FS catalyze the biosynthesis of A/B and Forssman (FORS1) oligosaccharide antigens that are responsible for the distinct blood group systems of ABO and FORS. Using genetic engineering, DNA transfection, and immunocytochemistry and immunocytometry, we have previously shown that the eukaryotic expression construct encoding human AT, whose LeuGlyGly tripeptide at codons 266 to 268 was replaced with FS-specific GlyGlyAla tripeptide, induced weak appearance of FORS1 antigen. Recently, we have shown that the human AT complementary DNA constructs deleting exons 3 or 4, but not exons 2 or 5, induced moderate expression of FORS1 antigen. The constructs containing both the GlyGlyAla substitution and the exon 3 or 4 deletion exhibited an increased FS activity. Here, we report another molecular mechanism in which an amino acid substitution at codon 69 from methionine to threonine or serine (Met69Thr/Ser) also modified enzymatic specificity and permitted FORS1 biosynthesis. Considering that codon 69 is the first amino acid of exon 5 and that the cointroduction of Met69Thr and GlyGlyAla substitutions also enhanced FS activity, the methionine substitutions may affect enzyme structure in a mode similar to the exon 3 or 4 deletion but distinct from the GlyGlyAla substitution.
© 2018 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29898878      PMCID: PMC6020805          DOI: 10.1182/bloodadvances.2018017293

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  41 in total

1.  The ABO blood group system: historical background.

Authors:  W M Watkins
Journal:  Transfus Med       Date:  2001-08       Impact factor: 2.019

2.  A study of the cellular distribution of Forssman antigen in various species.

Authors:  E H LEDUC; N TANAKA
Journal:  J Immunol       Date:  1956-09       Impact factor: 5.422

3.  A new variant of blood group A. Apae.

Authors:  R Stamps; R J Sokol; M Leach; R Herron; G Smith
Journal:  Transfusion       Date:  1987 Jul-Aug       Impact factor: 3.157

4.  Donor substrate specificity of recombinant human blood group A, B and hybrid A/B glycosyltransferases expressed in Escherichia coli.

Authors:  N O Seto; C A Compston; S V Evans; D R Bundle; S A Narang; M M Palcic
Journal:  Eur J Biochem       Date:  1999-02

5.  Sequential interchange of four amino acids from blood group B to blood group A glycosyltransferase boosts catalytic activity and progressively modifies substrate recognition in human recombinant enzymes.

Authors:  N O Seto; M M Palcic; C A Compston; H Li; D R Bundle; S A Narang
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

Review 6.  Blood group antigens as tumor markers, parasitic/bacterial/viral receptors, and their association with immunologically important proteins.

Authors:  G Garratty
Journal:  Immunol Invest       Date:  1995 Jan-Feb       Impact factor: 3.657

7.  Expression of Forssman glycolipid and blood group-related antigens A, Le(x), and Le(y) in human gastric cancer and in fetal tissues.

Authors:  K Uemura; H Hattori; K Ono; H Ogata; T Taketomi
Journal:  Jpn J Exp Med       Date:  1989-12

8.  Identification of alternative splicing markers for breast cancer.

Authors:  Julian P Venables; Roscoe Klinck; Anne Bramard; Lyna Inkel; Geneviève Dufresne-Martin; ChuShin Koh; Julien Gervais-Bird; Elvy Lapointe; Ulrike Froehlich; Mathieu Durand; Daniel Gendron; Jean-Philippe Brosseau; Philippe Thibault; Jean-Francois Lucier; Karine Tremblay; Panagiotis Prinos; Raymund J Wellinger; Benoit Chabot; Claudine Rancourt; Sherif Abou Elela
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

9.  The structural basis for specificity in human ABO(H) blood group biosynthesis.

Authors:  Sonia I Patenaude; Nina O L Seto; Svetlana N Borisova; Adam Szpacenko; Sandra L Marcus; Monica M Palcic; Stephen V Evans
Journal:  Nat Struct Biol       Date:  2002-09

10.  An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype.

Authors:  Irina M Shapiro; Albert W Cheng; Nicholas C Flytzanis; Michele Balsamo; John S Condeelis; Maja H Oktay; Christopher B Burge; Frank B Gertler
Journal:  PLoS Genet       Date:  2011-08-18       Impact factor: 5.917

View more
  3 in total

1.  ABO blood group A transferase and its codon 69 substitution enzymes synthesize FORS1 antigen of FORS blood group system.

Authors:  Miyako Yamamoto; Maria Cristina Tarasco; Emili Cid; Hidetomo Kobayashi; Fumiichiro Yamamoto
Journal:  Sci Rep       Date:  2019-07-04       Impact factor: 4.379

2.  The Usefulness of Rare Blood Group Systems in the Risk Determination for Severe COVID-19.

Authors:  Theocharis G Konstantinidis; Valeria Iliadi; Georges Martinis; Maria Panopoulou
Journal:  Pathophysiology       Date:  2021-11-03

3.  Possible Link Between the ABO Blood Group of Bioprosthesis Recipients and Specific Types of Structural Degeneration.

Authors:  Olivier Schussler; Nermine Lila; Juan Grau; Marc Ruel; Yves Lecarpentier; Alain Carpentier
Journal:  J Am Heart Assoc       Date:  2020-07-23       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.